PMID: 9659869Jul 11, 1998Paper

Smoking cessation treatment for patients with schizophrenia

The American Journal of Psychiatry
J AddingtonD Addington

Abstract

This study was an uncontrolled trial to assess the efficacy of a smoking cessation group program modified for individuals with schizophrenia. Fifty outpatients with schizophrenia were divided into five groups who met separately for seven weekly sessions of a smoking cessation program. The subjects' schizophrenic and extrapyramidal symptoms were assessed before the group sessions began and after they had been completed. Assessments of smoking were made at those times and at 3-month and 6-month follow-ups. Forty-two percent of the subjects had stopped smoking at the end of the group sessions; 16% remained abstinent at 3 months, and 12% at 6 months. These changes were statistically significant. There was no change in the positive or negative symptoms of schizophrenia. The results suggest that it is possible for individuals with schizophrenia to stop smoking.

Citations

Dec 1, 2007·Community Mental Health Journal·Shawn R CurrieNady El-Guebaly
Dec 1, 2014·Current Addiction Reports·Sarah C AkermanAlan I Green
Jul 24, 2012·Current Psychiatry Reports·Kristen M MackowickTony P George
Aug 9, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jennifer W TideyRobert M Swift
Dec 4, 2003·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Peter A VanableStephen A Maisto
Sep 28, 2004·Der Nervenarzt·K Cattapan-LudewigF Hasler
Nov 1, 2003·Psychiatry·Ashwin A PatkarFrank T Leone
Feb 20, 2009·Wiener medizinische Wochenschrift·Friederike D WernzAnil Batra
Jan 8, 2003·Psychosomatics·Oliver Freudenreich, Theodore A Stern
Feb 18, 2004·International Journal of Nursing Studies·Kuei-Ru ChouRu-Band Lu
Aug 23, 2006·Issues in Mental Health Nursing·Marsha Snyder
Nov 30, 2010·Schizophrenia Research·Monica C Mann-WrobelM Patricia Ball
Apr 7, 2010·Journal of Substance Abuse Treatment·Jill M WilliamsDouglas M Ziedonis
Sep 24, 2008·Archives of Psychiatric Nursing·Marsha SnyderSusan Painter
Feb 29, 2008·International Journal of Nursing Studies·Margaret A Green, Pamela G Hawranik
Aug 28, 2007·The Psychiatric Clinics of North America·Deanna L KellyRobert R Conley
Mar 2, 2005·Journal of Advanced Nursing·Tim BradshawNeil Harris
Jun 3, 2011·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marc De HertChristoph U Correll
Apr 27, 2012·International Journal of Mental Health Nursing·Tim Bradshaw, Rebecca Pedley
Apr 27, 2012·International Journal of Mental Health Nursing·Brenda HappellDavid Scott
Jul 17, 2010·Journal of Psychiatric and Mental Health Nursing·T BradshawM Campbell
Dec 2, 2011·Annals of the New York Academy of Sciences·Victoria C WingTony P George
Nov 25, 2004·Addictive Behaviors·Marc L SteinbergDouglas M Ziedonis
Sep 30, 2006·International Journal of Nursing Studies·Debbie Robson, Richard Gray
Sep 26, 2006·Preventive Medicine·Manuela Etter, Jean-François Etter
Jul 4, 2006·Schizophrenia Research·Jose de LeonManuel Gurpegui
Sep 20, 2005·General Hospital Psychiatry·Benjamin G Druss
Apr 12, 2005·Biological Psychiatry·Margaret A FonderTony P George
Sep 13, 2005·Behaviour Research and Therapy·Yong CuiRobert S Levine
Feb 12, 2014·American Journal of Preventive Medicine·Lisa Muirhead
Jan 7, 2004·Australian and New Zealand Journal of Public Health·Stephen R KiselyPeter Shannon
Aug 28, 2015·European Archives of Psychiatry and Clinical Neuroscience·Bo-Jian Wu, Tsuo-Hung Lan
Nov 5, 2005·Psychiatric Rehabilitation Journal·Gary S SkrinarPatrick Glew
Jul 17, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Amy V LukowskiDavid Tinkelman
Jul 5, 2011·Drug and Alcohol Dependence·Judson A BrewerBruce J Rounsaville
Mar 20, 2014·Annals of General Psychiatry·Hiranya WijesunderaVaruni A de Silva
Sep 4, 2012·Psychiatry Research·Aziz FerchiouFranck Schürhoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.